Suzhou Fushilai Pharmaceutical Co., Ltd.

SZSE:301258 Voorraadrapport

Marktkapitalisatie: CN¥2.4b

Suzhou Fushilai Pharmaceutical Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Suzhou Fushilai Pharmaceutical has a total shareholder equity of CN¥1.9B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.1B and CN¥187.4M respectively.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

CN¥0

Schuld

Rente dekkingsration/a
ContantCN¥1.38b
AandelenCN¥1.89b
Totaal verplichtingenCN¥187.38m
Totaal activaCN¥2.08b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

There May Be Reason For Hope In Suzhou Fushilai Pharmaceutical's (SZSE:301258) Disappointing Earnings

Oct 30
There May Be Reason For Hope In Suzhou Fushilai Pharmaceutical's (SZSE:301258) Disappointing Earnings

Suzhou Fushilai Pharmaceutical (SZSE:301258) Is Increasing Its Dividend To CN¥0.6005

Jun 07
Suzhou Fushilai Pharmaceutical (SZSE:301258) Is Increasing Its Dividend To CN¥0.6005

Analyse van de financiële positie

Kortlopende schulden: 301258's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥126.2M).

Langlopende schulden: 301258's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥61.2M).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 301258 is debt free.

Schuld verminderen: 301258 had no debt 5 years ago.

Schuldendekking: 301258 has no debt, therefore it does not need to be covered by operating cash flow.

Rentedekking: 301258 has no debt, therefore coverage of interest payments is not a concern.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y